The Enterprise Value as of December 2025 (TTM) for Vascular Biogenics Ltd. (VBLT) is -7381410.00

According to Vascular Biogenics Ltd.’s latest financial reports and current stock price. The company's current Enterprise Value is -7381410.00. This represents a change of 302.18% compared to the average of -1835352.15 of the last 4 quarters.

Vascular Biogenics Ltd. (VBLT) Historical Enterprise Value (quarterly & annually)

How has VBLT Enterprise Value performed in the past?

The mean historical Enterprise Value of Vascular Biogenics Ltd. over the last ten years is 2.93B. The current -7381410.00 Enterprise Value has changed -125.22% with respect to the historical average. Over the past ten years (40 quarters), VBLT's Enterprise Value was at its highest in in the June 2021 quarter at 5.67B. The Enterprise Value was at its lowest in in the March 2023 quarter at -13383594.96.

Vascular Biogenics Ltd. (VBLT) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Vascular Biogenics Ltd. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Vascular Biogenics Ltd. (VBLT) Average Enterprise Value

How has VBLT Enterprise Value performed in the past?

The current Enterprise Value of Vascular Biogenics Ltd. (VBLT) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Vascular Biogenics Ltd. (VBLT) Enterprise Value vs. Peers

How is VBLT’s Enterprise Value compared to its peers?

Vascular Biogenics Ltd.’s Enterprise Value is less than TuHURA Biosciences, Inc. (44.21M), less than Axcella Health Inc. (-2482600.00), less than Synaptogenix, Inc. (9.46M), less than Gelesis Holdings, Inc. (66.48M), greater than SQZ Biotechnologies Company (-28631213.00), less than Reunion Neuroscience Inc. (-7193195.00), greater than Applied Molecular Transport Inc. (-14017713.00), less than Scorpius Holdings, Inc. (20.57M), less than ObsEva S.A. (5.60M), less than Cyclacel Pharmaceuticals, Inc. (-998193.00),

Build a custom stock screener for Vascular Biogenics Ltd. (VBLT) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Vascular Biogenics Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Vascular Biogenics Ltd. (VBLT) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Vascular Biogenics Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.